Latest Blog Posts
Search
Sort Results
Filter by Programming
Filter by Specific Population
Filter by Topic
Filter by Infection
- HIV (remove)
Filter by Resource Category
- Research summary (remove)
Search results
Current filters: Treatment, Research summary, Reproductive and maternal health, HIV
14 search results
- Decreasing the risk of neural tube defects with dolutegravir
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - FDA warns that Prezcobix should not be used by HIV-positive pregnant women
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Agencies issue caution about use of dolutegravir by pregnant HIV-positive women
-
2018, CATIE
Research summary - Webpage - Quebec study is reassuring about the safety of HIV treatment during pregnancy
-
2017, CATIE
Research summary - Webpage - Canadian HIV treatment, care and support guidelines
-
From Prevention in Focus - Fall 2017
2017, CATIE
Research summary - Webpage - Canadian researchers review the use of raltegravir in pregnancy
-
2016, CATIE
Research summary - Webpage - U.S. study reviews use and impact of integrase inhibitors in pregnancy
-
2016, CATIE
Research summary - Webpage - Dolutegravir and the fetus
-
From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage - Dolutegravir—Interaction with atazanavir during pregnancy
-
From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage - A successful pregnancy and birth outcome with dolutegravir-based ART
-
From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage
